Stanford University
Showing 1,621-1,640 of 1,922 Results
-
Prashanth Krishnamohan, MD
Clinical Associate Professor, Adult Neurology
Clinical Associate Professor (By courtesy), NeurosurgeryBioDr. Krishnamohan is a board-certified, fellowship-trained neurologist. He is a clinical assistant professor of neurology and neurological sciences and, by courtesy, of neurosurgery at Stanford University School of Medicine. In addition, he is Medical Director of the Neurosciences Service Line at Stanford Health Care – ValleyCare and is Medical Director of its Stroke program.
Dr. Krishnamohan excels in the diagnosis and treatment of neurological conditions. His clinical interests include the management of stroke, epilepsy, concussion, and coma. With every patient, his goal is to provide personalized care designed to optimize neurological function for the best possible clinical outcome and quality of life.
He has published extensively on topics including innovations in stroke care quality management and measurement, rapid bedside evaluation of seizures in the ICU, and EEG metrics in comatose cardiac arrest patients. Articles by Dr. Krishnamohan have appeared in Neuroanesthesia and Neurocritical Care, Quality Management in Healthcare, Current Infectious Disease Reports, and other journals. He has presented his research findings at the annual meetings of the Neurocritical Care Society and American Academy of Neurology.
He has authored chapters on post-concussive syndrome, stroke, and other conditions for the guidebook Ferri’s Clinical Advisor. In addition, he is a reviewer for the Journal of Neuroscience Nursing, Neurohospitalist, and the Journal of Neurology, Neurosurgery, and Psychiatry.
Dr. Krishnamohan has won recognition from Stanford Health Care, the Institute for Healthcare Improvement Open School, the University of Kentucky College of Medicine, and PSG Institute of Medical Sciences and Research – the latter two his alma maters.
Dr. Krishnamohan is a member of the Neurocritical Care Society, American Academy of Neurology, and American Heart Association/American Stroke Association. He volunteers as a community health educator with numerous organizations. -
Anandi Krishnan
Affiliate, Institute for Immunity, Transplantation, and Infection Operations
Visiting Scholar, Institute for Immunity, Transplantation, and Infection OperationsBioDr. Krishnan is a translational scientist with experiences in engineering, biosciences, molecular genetics and hematology. Having recently completed her NIH clinical scientist career development award (NHGRI 1K08HG010061-01A1, 2018-24), and NIH-supported research re-entry (NCATS 3UL1TR001085-04S1, 2016-18), Anandi’s interests are in expanding our understanding of the multifaceted function of anucleate blood platelets and their parent megakaryocytes in human disease.
Her current work, applying platelet transcriptome profiling and machine learning principles, aims to nominate novel clinically relevant strategies for personalized cancer and antiplatelet/antithrombotic therapy. Continued development of this research is likely to identify key mechanistic variables in platelet- and megakaryocyte-specific response to health and disease.
Recent contributions in both computational and mechanistic components of platelet and blood research lay the groundwork for sustaining contributions to the field of hematology genomic medicine (e.g. Shen et al PMID 34755136, Seetharam et al PMID 36712071, Kelliher et al PMID 37961700, Thomas & Krishnan PMID 38175681, Abbonante et al PMID 38165147, Jutzi et al PMID 35763665, Campbell et al PMID 36194487). Anandi was also was one of the first non-MD PhD scientist to be awarded the NHGRI K08 Clinical Scientist Research Career Development Award, the HTRS Mid-Career Research Award, and the MPN Research Foundation Challenge Grant Award, reflecting her consistent efforts bridging basic and clinical disciplines.
Select other recognitions include:
Member, Editorial Board, Journal of Thrombosis and Haemostasis (2024-)
Ad hoc Reviewer, NIH CSR Cancer and Hematological Disorders Study Section (2023, 24)
Host Mentor, ISTH Training Fellowship, International Society for Thrombosis and Haemostasis (2023)
Member, Minority Recruitment Initiatives Subcommittee, American Society of Hematology (2022-26)
Team Science Leadership Program at Stanford Medicine (2022)
Peer Mentor, Pathology Stanford Network for Advancement and Promotion (2021)
Research Mentor, Meharry Medical College, Nashville, Meharry-Stanford initiative *mentee selected for oral presentation & won 2nd place at Meharry (2021)
Thrombosis & Hemostasis Societies of North America Young Investigator Award (2020)
Invited Member and Panelist, NSF RESET Conference (2020)
Invited Member/Panelist, iRelaunch Return to Work Conference, Stanford Alumni Association (2018)
Featured twice by NIH NCATS in the ‘Features & Briefs’ & ‘Diversity Awardee Profiles’ webpages (2017,18)
Complete list of publications: https://pubmed.ncbi.nlm.nih.gov/?term=anandi+krishnan&sort_order=asc -
Siddharth Krishnan
Assistant Professor of Electrical Engineering, and by courtesy, of Bioengineering and of Materials Science and Engineering
Current Research and Scholarly InterestsThe Krishnan Lab develops bioelectronic devices, tools and systems for closed loop disease management. Our work is divided into the following broad areas:
1. Biohybrid electronics for therapy and sensing: we combine living cells as functional parts of implantable devices, leveraging their ability to produce complex biologic therapeutics in a constitutive or triggerable manner, and their ability to sense their complex dynamic environment. These efforts are focused on developed functional cures for diseases like Type I Diabetes and other conditions requiring the regular infusion of proteins, peptides or antibody drugs.
2. Digital drug release systems for particulate forms of biologic drugs: Many complex protein and peptide drugs are not stable in solution, thereby frustrating the ability to delivery them through pumps and autoinjectors. This need is particularly acute for drugs that need to be administered as emergency rescue therapies, such as glucagon in the context of type 1 Diabetes. We develop implantable, miniaturized microelectromechanical devices that can store particulate (powders, pills) forms of these drugs and release them in a close loop manner based on wireless inputs from sensors.
3. Wearable sensors: Wearables to detect biophysical (temperature, flow, cardiac activity) and biochemical markers of health are gaining importance for closed-loop disease management and personalized medicine. We design hardware for on-chip molecular profiling based on sampling biofluids in noninvasive or minimally invasive formats.
4. New wireless power architectures for implantable bioelectronics: We develop high-power, high-efficiency strongly coupled power harvesting system to power battery-free implant systems.
